Revolutionizing
Neurological Care with
AI-Driven Precision
AI-powered platform delivering real-time, personalized insights to optimize neurological treatment, improve patient recovery and reducing healthcare costs.
MyndLink
AI-Powered Intelligence for Transforming Neurological Treatment
The Problem
60-70% of stroke survivors experience persistent upper limb impairment 1, 2, 3 despite 850,000 annual cases in North America 4. Similarly, 30% of the 50,000+ annual Spinal Cord Stimulator procedures fail 5, 6, with costs of $85,672-$155,748 per patient 7 resulting in over $1 billion in annual waste from failed procedures. These parallel challenges in neurological care highlight the urgent need for AI-powered solutions that can predict treatment success and personalize patient care.
1. PMC Rehabilitation Study (2022), 2. Vivistim Upper Limb Impairment Review (2022), 3. ACNR Journal (2019), 4. American Heart Association, 2024; CDC Stroke Facts 2024, 5. Pubmed, 2019; American Academy of Family Physicians, 2025, 6. Hadanny et al. 2022; Dougherty et al. 2021, 7. Kumar & Bishop, 2009, 6. Hadanny et al. 2022; Dougherty et al. 2021, 7.. Kumar & Bishop, 2009
The Solution
MyndTec is developing MyndLink, an AI-powered solution that transforms neurological treatment by predicting outcomes, optimizing protocols, and automating clinical workflows. Using advanced predictive analytics and ambient listening, MyndLink eliminates administrative burden, optimizes treatment protocols in real-time, and generates the objective outcome data required for value-based care. The result: facilities increase revenue, patients achieve better recovery, and healthcare systems save billions.
MyndTec leverages over a decade of expertise in neurological care and regulatory success to drive AI innovations that transform outcomes and reduce costs.
MyndMove
Our First Product in Neurological Care
MyndMove™ is a non-invasive therapy designed to help patients with paralysis from stroke or spinal cord injury regain movement and improve quality of life. By using electrical signals, MyndMove stimulates the brain to form new neural connections, a process known as neuroplasticity, which aids in recovery and rebuilding strength. Clinical studies show significant improvements in movement and function, even when other treatments have not been effective. Authorized in both the U.S. and Canada, MyndMove offers personalized neuromodulation settings to enhance motor control and sensation.
Cell Regeneration Technology
Repairing the Brain from Within
MyndTec’s cell regeneration technology, currently in preclinical study, uses patients' own neural stem cells, guided by electrical stimulation, to support brain tissue repair and potentially improve outcomes in neurological conditions such as Parkinson’s, stroke, and Alzheimer’s.
